Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 1Melanoma 1Hypertension 1Heart Failure 1

Interventions

Echocardiography 3Electrocardiography 2Blood Specimen Collection 2ziprasidone 1Zolpidem 1Watchful Waiting 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1Specimen Handling 1Sevelamer 1Rocuronium 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lenalidomide 1Labetalol 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Heart Failure × Angiotensin-Converting Enzyme Inhibitors × Clear all
NCT02818517 2022-02-02

Evaluation and Management of Cardio Toxicity in Oncologic Patients

Tel-Aviv Sourasky Medical Center

Recruiting
1,000 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡